Javier Weisson, MD

Development of Primary Cutaneous Anaplastic Large Cell Lymphoma Following Treatment With Upadacitinib for Atopic Dermatitis

Publish date: February 25, 2026

A 22-year-old man presented to our clinic with a history of longstanding widespread recalcitrant atopic dermatitis (AD) since early childhood.